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ABSTRACT: Recent research—in which subjects were studied longitudinally from childhood until adulthood—has started to clarify how a child’s
environment and genetic makeup interact to create a violent adolescent or adult. For example, male subjects who were born with a particular allele
of the monoamine oxidase A gene and also were maltreated as children had a much greater likelihood of manifesting violent antisocial behavior as
adolescents and adults. Also, individuals who were born with particular alleles of the serotonin transporter gene and also experienced multiple stressful life events were more likely to manifest serious depression and suicidality. This research raises the question of whether testimony regarding a
defendant’s genotype, exposure to child maltreatment, and experience of unusual stress is appropriate to present during the guilt or penalty phases of
criminal trials, especially when capital punishment is a consideration. The authors present their experience in genotyping criminal defendants and presenting genetic information at criminal trials.
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Mental health professionals have thought for many years that
violent behavior is partly caused by a person’s life experiences and
partly by genetic influences. Recent research—in which subjects
were studied longitudinally from childhood until adulthood—has
started to clarify how a child’s environment, his subsequent exposure to stressful life events and his genetic makeup may interact to
create an increased risk for violence and other mental disorders in
adolescence and adulthood. This interaction between genetic loci
and life experiences is called gene · environment (G · E)
interaction.
We agree with Paul S. Appelbaum, who said, ‘‘Recent research
findings…suggest that behavioral genetics may be the next frontier
for the world of criminal justice, and mental health professionals
are likely to play a critical role in helping the courts make sense of
the new data’’ (1). Other experts, Popma and Raine, said, ‘‘Exciting
progress is being made in the knowledge concerning genetic contributions to antisocial behavior and the interplay of genetic factors
with the environment. …One probable important pathway is that
genetic factors influence biologic factors, such as arousal and hormonal levels, as well as specific aspects of brain functioning, which
in turn influence behavior’’ (2).
For example, Caspi et al. (2002) (3) studied the monoamine oxidase A (MAOA) gene. When there is a low activity of this gene,
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neurotransmitters in the brain (serotonin, dopamine, and norepinephrine) are not properly metabolized. They found that when male
subjects had a low activity of MAOA and also were maltreated as
children, there was a much greater likelihood the person would
manifest violent antisocial behavior in the future. Also, Caspi et al.
(2003) (4) studied the 5-HTT (5-hydroxytryptamine or serotonin
transporter) or SLC6A4 gene. They found that individuals with one
or two copies of the short allele ‘‘exhibited more depressive symptoms, diagnosable depression, and suicidality in relation to stressful
life events’’ than individuals with two long alleles.
Information regarding a defendant’s genotype, exposure to child
maltreatment, and experience of unusual stress may be appropriate
to present during the guilt and penalty phases of criminal trials,
especially when capital punishment is a consideration. This paper
summarizes both historical and recent research regarding possible
biopsychosocial causes of violence, summarizes the history of court
testimony regarding these issues, and relates our experience in conducting MAOA and SLC6A4 genotyping and testifying regarding
these topics in criminal trials.
The Search for the Causes of Violent Behavior
Early attempts to explain criminal behavior on the basis of
inherited genetic predisposition focused on phenotype rather than
genotype. In the late nineteenth century, Lombroso attempted to
predict criminality based on ‘‘primitive’’ physical characteristics
such as strong jaws, heavy brows, bloodshot eyes, thick lips, and
projecting ears (5,6). While these characteristics may have correlated to some degree with low intelligence and some rare genetic
syndromes, they were far from being valid indicators of
criminality.
Sheldon also put forth a theory of criminality based on physical
characteristics. He hypothesized that a mesomorphic or muscular
body type was predictive of criminal behavior (7). Although some
research has supported a mild association with degree of
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mesomorphy and criminality, it is not a consistent finding and certainly does not explain the vast majority of criminal behavior.
Many researchers have studied families of criminals and have
consistently found higher rates of criminal behavior among offspring of criminals. This suggests a genetic component to criminality but does not sufficiently account for environmental influences.
Twin and adoption studies have attempted to separate these variables. For example, Kendler and Prescott (8) and other researchers
at the Virginia Adult Twin Study of Psychiatric and Substance Use
Disorders have studied several thousand sets of twins for more than
20 years. They have shown that conduct disorder in adolescents
and antisocial behavior in adults is related to both genetic and environmental factors, and they demonstrated gene · environment
interactions.
The focus on genotype rather than phenotype was addressed at
the chromosomal level. Men with an XYY karyotype were once
thought to be more aggressive and violent, but this theory was largely disproved by larger, population-based studies. However, the
presence of the extra Y chromosome may confer some greater risk
for antisocial behavior because of an association with learning
problems and low intelligence (9,10).
With an understanding of molecular genetics and completion of
the human genome project, scientists are able to isolate specific
genes and inch closer to uncovering the secrets of the ‘‘black box’’
of genetics that were only inferred by the classical approaches
described above. Much research has focused on genes involving
major neurotransmitters such as serotonin and dopamine and proteins that affect these neurotransmitters. No research has yet to isolate a specific ‘‘crime gene’’ and probably none ever will. Some of
the reasons this is unlikely are incomplete penetrance, genetic
heterogeneity, and the complex interaction among environmental
factors, development, and gene expression.
Testimony Regarding MAOA Genotyping
Although criminal defendants have introduced evidence of
genetic predispositions to violence, alcoholism, antisocial personality disorder, and other associated traits in criminal trials, specific genotyping evidence has been introduced on an extremely
limited basis (11,12). Owing in part to procedural hurdles and in
part to the inadequacy of the science in establishing a link
between a defendant’s biological make-up and the specific
alleged criminal act, genetic predisposition evidence has had only
limited effect in criminal cases. New advances in behavioral sciences may enable a greater impact of such evidence in future
criminal cases. The few reported cases in which evidence pertaining to the MAOA gene or serotonin has been introduced in
criminal trials are summarized here. Of course, testimony regarding the MAOA gene and serotonin may have been introduced in
other cases, including some cases without written opinions or
cases where the opinion makes no mention of the genetic testimony introduced.
Mobley v. State
The 1994 criminal case of Stephen A. Mobley is the sole
reported case referencing MAOA genotyping (13). Mobley was convicted of murder, armed robbery, aggravated assault, and possession
of a firearm during the commission of a crime and was sentenced
to death. At trial, Mobley filed a motion seeking funds to hire
expert witnesses to assess his potential deficiency in MAOA enzymatic activity, based on the then-recent studies suggesting ‘‘a possible genetic basis for violent and impulsive behavior in certain
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individuals,’’ and his family history of violence (14). This motion
was based on a recently published study by Brunner et al. (15), in
which a family in The Netherlands was identified in which very
violent individuals had a specific mutation of the MAOA gene. The
trial court denied Mobley’s motion, finding that the link between
the MAOA gene and violence lacked scientific verifiability sufficient for it to be introduced during the sentencing phases of his
capital trial. On March 1, 2005, Mobley was executed by lethal
injection by the state of Georgia.
Testimony Regarding Serotonin
No published court opinion documents the use of serotonin transporter gene (SLC6A4) genotyping as evidence during trial. Expert
testimony has been cited, however, regarding a defendant’s serotonin level in the central nervous system, its effect on impulse control, the consequent ability of the defendant to form the requisite
intent for the alleged crime, and to mitigate a defendant’s culpability for sentencing. What follows is a summary of the few cases in
which expert testimony regarding a defendant’s serotonin levels
was referenced in court opinions.
State v. Jon Hall
Jon Hall was convicted of the 1994 first-degree murder of his
estranged wife (16). During a postconviction hearing on appeal,
Hall’s lawyers presented an expert witness who testified Hall had
low serotonin levels in his brain, consistent with intermittent
explosive disorder. Another expert explained that low levels of
serotonin serve as a biological marker for intermittent explosive
disorder and that the scientific literature confirmed a ‘‘correlation
between low levels of serotonin in the brain and violent acts’’
(p. 16) (16). The expert concluded that Hall was ‘‘unable…to
achieve the mental state of the absence of passion and excitement,’’ necessary for a finding of criminal liability (p. 18) (16).
The state responded with expert testimony rebuking these claims.
The state’s expert testified that measuring serotonin in the cerebrospinal fluid (CSF) lacked utility as a diagnostic tool because it
failed to give an accurate indication of the serotonin levels in the
synapses where it operates and that there was no consensus on
what constitutes normal levels of serotonin. The procedural posture of the case rendered the dispute between the experts irrelevant; the theory of intermittent explosive disorder was unavailable
at the time of Hall’s trial, and presented only later on appeal.
The unavailability of the theory at the time of trial undermined
Hall’s claim of ineffective assistance of counsel at trial for failure
to present the theory as a defense. Hall’s conviction and death
sentence were affirmed.
Hines v. State
Similarly, Anthony Darrell Hines, originally tried and convicted
of first-degree felony murder and sentenced to death in 1986, failed
on his claim of ineffective assistance of counsel for failure to introduce evidence of his low serotonin levels during his 1989 re-sentencing hearing (17).
State v. Payne
In two other murder cases in Tennessee, defense counsel proceeded on analogous defense theories. In State v. Payne, Derek
T. Payne was charged with a two-count indictment of first-degree
premeditated murder, first-degree felony murder, and one count of
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criminal attempt to commit especially aggravated robbery (18).
The jury found him guilty of the lesser-included offense of second-degree murder and attempted especially aggravated robbery,
and he was sentenced to 37 years in prison. A molecular neurobiologist provided expert testimony during trial that Payne had
statistically low serotonin levels, and explained the interrelationship between serotonin and human behavior. The neurobiologist
also testified that ‘‘the research in the field has consistently shown
a link between low serotonin levels and ‘explosive intermittent
violence’’’ (p. 5) (18). Although he acknowledged that low serotonin itself does not cause violence, the neurobiologist concluded
that Payne’s ‘‘capacity to control [an] impulse once it had
occurred [was] virtually nonexistent’’ (p. 5) (18). In accord with
the scientific literature, however, the neurobiologist opined that
serotonin would be relevant only to a crime of impulse, rather
than a planned or premeditated one.
The expert testimony was introduced for several purposes: (1)
to claim Payne could not form the requisite mental state
required for first or second-degree murder because of his low
serotonin levels; (2) to support the claim that Payne committed
voluntary manslaughter because he acted based on provocation
by the victim and lack of impulse control; and (3) as mitigating
evidence during sentencing. Prior to deliberations, the court
instructed the jury that Payne’s mental condition could have
affected his capacity to form the requisite mental state for the
particular offense. The jury found Payne guilty of the lesserincluded offense of second-degree murder, thereby rejecting his
claims. The appellate court affirmed, explaining that although
Tennessee recognizes the defense of diminished capacity, the
jury reasonably could have rejected Payne’s defense to seconddegree murder, relying instead upon the circumstantial evidence
suggesting that Payne premeditated the murder rather than acting
impulsively. Notably, the jury did not convict Payne of firstdegree murder. The jury instructions and limited evidence Payne
introduced to negate his mental state—his low serotonin level
and laboring under the influence of alcohol and cocaine during
the crime—could suggest that the jury’s decision to find Payne
guilty of second-rather than first-degree murder was impacted by
the expert testimony. The appellate court concluded that Payne’s
subjective serotonin level was irrelevant, however, to the defense
of provocation (and therefore voluntary manslaughter), which is
judged by the external circumstances of the crime, rather than
the internal mental state of the defendant. Finally, the appellate
court agreed that Payne’s low serotonin levels could be afforded
little weight as mitigating evidence because the circumstances of
the crime suggested that Payne did not act impulsively, but in a
calculated manner.
State v. Godsey
A similar defense of diminished capacity was raised in State v.
Godsey, in which Garland Godsey was indicted for premeditated
first-degree murder, but convicted of the lesser-included offense of
second-degree murder and sentenced to 25 years incarceration (19).
At trial, the defense introduced expert testimony diagnosing the
defendant with intermittent explosive disorder, suggesting he has
only an extremely limited capacity to control his aggressive
impulses, and thereby could not form the requisite mental state
required for first- or second-degree murder. In addition, the defense
introduced testimony that Godsey was inebriated during the commission of the homicide and therefore acted in an impulsive rather
than premeditated fashion. Godsey, too, was convicted of secondrather than first-degree murder.

People v. Uncapher
Low brain serotonin level has also been introduced as a defense
in other jurisdictions. In People v. Kenneth John Uncapher, a
Michigan trial court excluded expert testimony diagnosing Uncapher with low levels of serotonin, and testimony linking low levels
of serotonin with poor impulse control (20). Uncapher’s lawyers
sought to introduce this testimony to support the claim that Uncapher ‘‘had ‘biological’ problems that diminished his ability to reason and control his impulses’’ (p. 1) (20). The Michigan trial court
found such testimony impermissible because Michigan law prohibits the use of a defendant’s psychological or biological condition to
rebut his capacity to form the requisite mental state for the alleged
crime. Instead, such evidence is permissible in Michigan only in
support of an insanity defense.
State v. Sanders
An Ohio trial court similarly excluded expert testimony regarding a defendant’s bipolar affective disorder, aggravated by low
serotonin levels in the defendant’s brain, and his consequent
impaired capacity to control his impulsive behavior (21). The
defendant, Dion Wayne Sanders, claimed that the testimony would
prove that he was ‘‘incapable of acting with the degree of culpability which the charges of Aggravated Murder involved’’ (p. 1) (21).
The State objected to the testimony, arguing that diminished capacity is not a defense to criminal liability, and is admissible only in
support of an insanity defense. The trial court excluded the testimony, and the appellate court affirmed, finding that ‘‘[w]hether an
accused acted out of a sense or attitude of rage is not relevant to
prove that he acted or did not act ‘purposefully’ and ‘with prior calculation and design.’ …It could not demonstrate that when he shotgunned his grandparents Sanders lacked the specific intent to kill
them. It only demonstrates that he was enraged when he did’’
(p. 2) (21).
Other jurisdictions that prohibit the defense or evidentiary rule of
diminished capacity may likewise prohibit the use of MAOA and
SLC6A4 genotyping evidence to negate the defendant’s capacity to
form the requisite intent for the crime. In those jurisdictions, such
evidence may still be relevant to the insanity defense or during sentencing. At the trial of Dion Wayne Sanders, for example, after the
trial court excluded testimony regarding the defendant’s low serotonin in the CSF during the guilt phase of the trial, testimony regarding the ‘‘serotonin defense’’ was introduced during the penalty
phase of the trial. The defense argued that Sanders inherited a predisposition for low serotonin brain activity, which left him vulnerable for impaired impulse control. Sanders also had a family history
of violence associated with alcoholism. Also, Sanders had been
using cocaine heavily prior to the murders. Although the jury found
Sanders guilty of capital offenses, they returned verdicts of life
without parole rather than the death penalty (22).
State v. Newton
In another Ohio case, the court denied a capital defendant’s
motion requesting funding for neuropsychiatric testing to ‘‘help
explain [the defendant’s] impulsiveness and alleged criminal behavior’’ (23). The defense requested the court to reconsider, pointing to
‘‘literature indicating a link between low levels of the brain chemical serotonin and deficient impulse control, leading to pyromania,
suicide, and severe aggression,’’ and arguing that such tests could
provide mitigating evidence (p. 609) (23). The appellate court
affirmed, noting two hurdles: (1) ‘‘Newton’s claim that a low
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serotonin level is related to impulsivity simply did not matter since
Newton failed to demonstrate that tests performed in December
2002 could be useful in determining Newton’s brain chemistry in
November 2001, when the offense occurred’’ (p. 609) (23), and (2)
the funding denial was not prejudicial as the circumstances of the
crime demonstrated planning and calculation by the defendant
rather than impulsivity (p. 610) (23). More specific genotyping evidence would overcome the first hurdle, but a defendant would still
need to demonstrate a causal link between his genotype and the
criminal act in question.
State v. Hill
Finally, in South Carolina, David Hill was convicted of firstdegree murder and sentenced to death in 1995. During the sentencing phase of his capital trial, Hill’s lawyers introduced expert
testimony to establish that Hill suffered from a genetically based
serotonin deficiency, which caused him to have aggressive impulses
(24). His lawyers argued the death penalty was unwarranted
‘‘because Hill’s aggressive behavior was genetic (i.e., beyond his
control) and treatable’’ (p. 202) (24). In support of this defense, his
lawyers introduced several experts to testify that Hill had chronically low serotonin levels (based on analysis of CSF), regarding
the role of serotonin on brain chemistry, and how genetics can
affect serotonin levels. The defense also introduced a psychiatrist to
testify that he had prescribed Prozac to Hill that Hill had responded
favorably, and the medication curbed his aggressive impulses.
Unfortunately, the psychiatrist suffered a breakdown on the stand
and was unable to answer questions. On appeal, Hill unsuccessfully
argued that he received ineffective assistance of counsel during trial
by calling the psychiatrist to the stand.
In short, specific evidence regarding the MAOA gene or serotonin abnormalities has been introduced in only a few criminal cases.
Such evidence may support the use of a defense of diminished
capacity, where permissible, to inform the trier of fact whether the
defendant had the capacity to form the requisite intent for the
alleged crime, or serve as mitigating evidence during sentencing.
Because of procedural obstacles or limitations in the scientific
research to date, such testimony has either been excluded or has
had minimal effect on trial outcome. In at least two cases, however,
such testimony may have influenced the jury’s decision to convict
the defendant of second-degree rather than first-degree murder. In
both cases, however, the defendant was convicted of murder rather
than manslaughter, suggesting those jurors did not believe the
defendant’s serotonin level rendered him incapable of forming the
intent to kill. If introduced during the initial trial, and presented
within the statutory limits of the respective jurisdiction, such evidence may play a more prominent role in future criminal cases.
MAOA and Environment Interaction
In the future, testimony regarding behavioral genetics will likely
go beyond the simplistic notions of the MAOA knockout gene and
low levels of a serotonin metabolite in the CSF. It is likely that
research regarding genetics and environmental interactions will be
the basis for such testimony. Research by Caspi et al. (3,4) and
others will be presented in legal settings.
Caspi et al. (2002) (3) ‘‘studied a large sample of male children
from birth to adulthood to determine why some children who are
maltreated grow up to develop antisocial behavior, whereas others
do not.’’ The subjects, who were followed from age 3 to age 26,
were members of the Dunedin Multidisciplinary Health and Development Study. The New Zealand researchers used a particular
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gene, the MAOA gene, to characterize genetic susceptibility to maltreatment. The MAOA gene is located on the X chromosome
(Xp11.23-11.4). This gene encodes the MAOA enzyme, which
metabolizes neurotransmitters such as serotonin, norepinephrine,
and dopamine. There are two alleles of the MAOA gene: one
results in high activity of the MAOA enzyme; the other results in
low activity of the MAOA enzyme. As this gene is on the X chromosome, a male has only one allele, either the high activity MAOA
or the low activity MAOA allele. A male with the low activity
MAOA allele will not metabolize serotonin, norepinephrine, and
dopamine in an efficient manner. In the Caspi et al. study, about
37% of the males had low activity of the MAOA enzyme.
When they characterized the subjects regarding childhood maltreatment, Caspi et al. (2002) (3) found that 8% of the children suffered ‘‘severe’’ maltreatment between ages 3 and 11; 28% of the
children suffered ‘‘probable’’ maltreatment; and 64% experienced
no maltreatment. These researchers found that when male subjects
had a low activity of the MAOA enzyme and also were maltreated
as children, there was a much greater likelihood the person would
manifest violent antisocial behavior in the future. They said, ‘‘For
adult violent conviction, maltreated males with the low-MAOA
activity genotype were more likely than nonmaltreated males with
this genotype to be convicted of a violent crime by a significant
odds ratio of 9.8.’’ The authors thought that this study illustrated a
model for gene-environment interaction. That is, they suggested
that the high activity MAOA allele protects the child against the
harmful biopsychosocial impact of maltreatment.
For purposes of testimony in criminal trials, it is useful to compare subjects who had low MAOA activity and severe maltreatment
with subjects who had high MAOA activity and no maltreatment.
In presenting mitigation, the point is that the defendant’s low
MAOA activity and severe child maltreatment were outside of his
control. If a defendant had both of those characteristics, he had vulnerability toward violent behavior. In analyzing the data of Caspi
et al. (2002) (3), we found that the relative risk for being convicted
of a violent offense was 4.6 for individuals who had low MAOA
activity and severe maltreatment compared with subjects who had
high MAOA activity and no maltreatment. See Table 1, which
indicates the relative risk for violent behavior, not the absolute risk.
Replication of Caspi et al. (2002)
The study by Caspi et al. (2002) (3) was replicated by several
other research teams which used varying definitions of child maltreatment, violent behavior, and genetic risk. The fact that the
results are mostly consistent even though there are a variety of
study designs should strengthen the conclusion that a G · E interaction increases one’s risk to be a violent person later in life. See
Table 2 for a summary of studies that addressed the relationship of
MAOA genotype, maltreatment, and antisocial behavior. There were
five studies (25–29) that replicated Caspi et al. (2002) (3). The two
studies (30,31) that did not replicate had significant limitations.
Kim-Cohen et al. recently reviewed this research, developed a
meta-analysis of these studies, and said, ‘‘Pooling estimates from
TABLE 1—Data adapted from Caspi et al. (2002).

Condition
High MAOA, no maltreatment
High MAOA, maltreatment
Low MAOA, maltreatment
MAOA, monoamine oxidase A.

Percent convicted of
violent offense

Relative
risk

7
20
32

1
2.9
4.6

Yes for males
Kim-Cohen et al. (29)

G · E, gene-environment; CD, conduct disorder; SA, substance abuse.

Mother and teacher reports on
child behavior checklist
Community twins, U.K.

Haberstick et al. (30)
Young et al. (31)
Nilsson et al. (28)

975 males, age 7

Mother and teacher reports on
child behavior checklist
Interview and violent convictions
Admission for CD or SA
Interview
1116 pairs of same-sex
twins, age 5
774 males, age 22
247 males, age 12–18
81 males, age 16–19
Community twins, U.K. Genetic
risk inferred by zygosity of twins
Community young adults, U.S.
Psychiatric inpatients, U.S.
Community adolescents, Sweden
Jaffee et al. (27)

Foley et al. (26)

SLC6A4 and Environment Interaction

Retrospective self-report
Retrospective self-report
Retrospective self-report and
living environment
Mother interview

Yes for males and
females taken together
No
No
Yes for males

Yes for males

Self-report of childhood adversity
by parent and child
Mother interview
CD, child and parent reports

Barratt Impulsivity Scale
342 males, average age 38

Psychiatric outpatients and normal
controls, U.S.
Community twins, U.S.
Huang et al. (25)

514 males, age 8–17

Yes for males

Yes for males

Parental observations and parental
report, retrospective self-report,
family changes
Retrospective self-report
Community birth cohort,
New Zealand
Caspi et al. (2002) (3)

CD, arrest record, self-report,
outside report

Sample composition, location

442 males, age 26

five studies, we found that the association between early familial
adversity and mental health was significantly stronger in the lowactivity MAOA versus the high-activity MAOA groups’’ (29).

Study

Sample size, gender, and age

Antisocial behavior measure

Maltreatment measure

Evidence of G · E interaction
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TABLE 2—Summary of studies investigating relationship of MAOA genotype, maltreatment, and antisocial behavior.
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Caspi et al. (2003) (4) addressed ‘‘why stress experiences lead to
depression in some people but not in others.’’ The subjects in this
study were also members of the Dunedin Multidisciplinary Health
and Development Study. The authors found another example of
G · E interaction, i.e., that a particular allele of the serotonin transporter gene appeared to protect individuals from the harmful biopsychosocial impact of multiple stressors.
The transporter is the cell membrane structure that recycles synaptic serotonin (5-hydroxytryptamine or 5-HT) for repackaging and
subsequent re-release. The serotonin transporter gene is referred to
as 5-HTT or SLC6A4. The SLC6A4 gene, which is located on chromosome 17, can have either a ‘‘long allele’’ or a ‘‘short allele.’’
The short allele of the SLC6A4 gene causes low activity of the
transporter system, which means there will be more serotonin in
the synapse and less serotonin available for reuse. For people with
the short allele, the serotonin system is not working efficiently. In
Caspi et al. (2003) (4), 17% of the subjects had two copies of the
short allele (S ⁄ S homozygotes), 31% had two copies of the long
allele (L ⁄ L homozygotes), and 51% had one copy of each allele
(S ⁄ L heterozygotes).
Caspi et al. (2003) (4) characterized the subjects as to whether
they had stressful life events after their 21st birthday and prior to
their 26th birthday. For example, they asked about stressful life
events related to employment, finances, housing, health, and relationships. They found the following frequency of stressful life
events: no stressful life events, 30% of the sample; one event, 25%
of the sample; two events, 20% of the sample; three events, 11%
of the sample; and four or more events, 15% of the sample. At
about age 26, they characterized the subjects as to whether they
had symptoms of serious depression. They found that 17% of study
members met criteria for a past-year major depressive episode and
3% of study members reported past-year suicide attempt or recurrent suicidal ideation. The authors showed that individuals with the
short allele of the 5-HTT were more susceptible to stress. Specifically, people with one or two copies of the short allele ‘‘exhibited
more depressive symptoms, diagnosable depression, and suicidality
in relation to stressful life events’’ than individuals with two long
alleles.
For purposes of testimony in criminal trials, it is useful to compare subjects who were homozygotic for the short allele (S ⁄ S) and
had four or more stressful life events with subjects who were
homozygotic for the long allele (L ⁄ L) and had no stressful life
events. In presenting mitigation, for instance, the point is that the
defendant’s low SLC6A4 activity and multiple stressful life experiences were outside of his control. If a defendant had both of those
characteristics, he had vulnerability toward depression and suicidality. In some circumstances, severe depression may be a factor in
mitigation. In analyzing the data of Caspi et al. (2003) (4), we
found that the relative risk for suicidality was 4.7 for individuals
who were S ⁄ S homozygote and had four or more stressful life
experiences compared with subjects who were L ⁄ L homozygote
and had no stressful life experiences. See Table 3. Also, we found
that the relative risk for major depressive disorder was 4.0 for individuals who were S ⁄ S homozygote and had four or more stressful
life experiences compared with subjects who were L ⁄ L homozygote and had no stressful life experiences. See Table 4.

Yes

1
1.5
4.7

No

3
4.5
14

Yes
Yes for females
Yes for females
No

Relative
risk

Yes for females
Yes

L ⁄ L Homozygote, no stressful life experience
L ⁄ L Homozygote, 4+ stressful life experiences
S ⁄ S Homozygote, 4+ stressful life experiences

Percent
suicidal

Yes

Condition

Evidence of G · E
interaction

TABLE 3—Data adapted from Caspi et al. (2003).

Yes, included LG allele

BERNET ET AL. • BAD NATURE, BAD NURTURE

SLE
G · E, gene-environment; MDD, major depressive disorder; SLE, stressful life events.

Depressed patients and
controls, U.S.
Zalsman et al. (36)

191 subjects, 125 controls, males
and females, mean age 38

Nonclinical adults, Australia
Wilhelm et al. (35)

127 males and females, mean age 48

Nonclinical adults, U.K.
Surtees et al. (40)

4175 males and females, age 41–80

MDD, rating scale,
interviews
MDD, interviews

Adverse experiences in childhood
and adulthood
SLE

SLE
Family environment risk
Unemployment, chronic diseases
SLE

MDD, interviews
Rating scale
Rating scale
MDD, depressive
symptoms, suicidality
MDD, rating scale

Family environment risk, SLE
Childhood maltreatment

MDD, depressive
symptoms, suicidality
Rating scale
Rating scale
847 males and females, age 26

157 males, 220 females, age 12–19
57 subjects, 44 controls, males
and females, age 5–15
549 males and females, mean age 35
66 males, 114 females, age 19–22
302 males, 674 females, mean age 52
1091 males and females, mean age 39
Kendler et al. (33)
Sjçberg et al. (34)
Grabe et al. (38)
Gillespie et al. (39)

The genotyping was performed by faculty of the Molecular
Genetics Laboratory, Vanderbilt University Medical Center (CVJ).
High molecular weight DNA was extracted from 350 lL of peripheral blood collected in EDTA tubes using the BioRobot EZ1 and
EZ1 DNA extraction kits according to the instructions from the
manufacturer (Qiagen Inc., Valencia, CA). Approximately
50–100 ng of patient DNA was used in each polymerase chain

Eley et al. (37)
Kaufman et al. (32)

Sample Preparation and PCR Amplification of the MAOA and
SLC6A4 Genes

Community birth cohort,
New Zealand
Nonclinical adolescents, U.K.
Children in state custody and
community controls, U.S.
Twin registry, U.S.
Nonclinical adolescents, Sweden
Nonclinical adults, Germany
Twin registry, Australia

Between August 2004 and October 2006, faculty of Vanderbilt
Forensic Services have arranged for MAOA and SLC6A4 genotyping of 15 defendants. All of these defendants were being prosecuted by the State of Tennessee for first-degree murder or
attempted first-degree murder, as well as other serious offenses in
some cases. In several cases, the state was seeking the death penalty. We conducted genotyping because we thought it might be relevant for the guilt phase of the trial (regarding diminished
capacity) and ⁄ or the penalty phase of the trial (regarding mitigation). In four cases, the defendants were minors, so the death penalty was not an issue. However, evidence regarding genotyping
may be relevant in transfer or waiver hearings, in which the court
decides whether a minor will be tried in juvenile court or criminal
court.
This research was reviewed by the Institutional Review Board
(IRB) of Vanderbilt University School of Medicine, and it was concluded this activity met criteria for Exempt Review. The IRB
noted, ‘‘The study poses minimal risk to participants.’’ The clinical
information presented below is either publicly available because it
was introduced at trial or is disguised to make it nonidentifiable.

Caspi et al. (2003) (4)

Methods

Stress measure

The general findings of Caspi et al. (2003) (4) were replicated
by several other research teams, which used varying definitions of
psychosocial stressors, psychological distress, and genetic risk.
They used a variety of study designs. See Table 5 for a summary
of studies that addressed the relationship of SLC6A4 genotype,
stressful life experiences, depression, and suicidality. Seven of these
studies replicated (32–36) or partly replicated (37,38) Caspi et al.
(2003). Two studies (39,40) did not replicate Caspi et al. (2003).
Also, research regarding the SLC6A4 polymorphism, stressful life
events, and depression was summarized and reviewed by Wurtman
(41) and Zammit and Owen (42).

Depression measure

Replication of Caspi et al. (2003)

Sample size, gender, and age

1
2.0
4.2

Sample composition, location

10
20
42

Study

L ⁄ L Homozygote, no stressful life experience
L ⁄ L Homozygote, 4+ stressful life experiences
S ⁄ S Homozygote, 4+ stressful life experiences

Percent with major Relative
depressive disorder risk
TABLE 5—Summary of studies investigating relationship between serotonin transporter genotype, stressful life events, and depression.

Condition

SLE, childhood maltreatment

TABLE 4—Data adapted from Caspi et al. (2003).
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reaction (PCR) assay. Amplification of the MAOA variable number
tandem repeat polymorphism was performed using oligonucleotide
primers specific for this locus as previously described by Caspi
et al. (2002) (3). However the forward primer was labeled with the
HEX fluorophore. The 15 lL PCR reaction contained 0.1 lM of
each primer and included an initial denaturation at 94C for 6 min
followed by 35 cycles each containing denaturation at 94C for
1 min, annealing at 62C for 1 min, and a 1.5 min extension at
72C. The amplification reaction concluded with a 10 min extension at 72C. Amplification of the SLC6A4 gene promoter polymorphism was performed using oligonucleotide primers specific for
this locus as first reported by Gelernter et al. (40). However, the
forward primer was labeled with the NED fluorophore. The 15 lL
PCR reaction contained 0.5 lM of each primer and included an
initial denaturation at 94C for 6 min followed by 35 cycles each
containing denaturation at 94C for 30 sec, annealing at 66C for
30 sec, and a 45 sec extension at 72C. The amplification reaction
concluded with a 10 min extension at 72C.
Capillary Electrophoresis and Analysis
One microliter of the PCR products were prepared for analysis
on the 3130xl Genetic Analyzer (Applied Biosystems, Foster City,
CA) by mixing with 19.5 lL of Hi-Di formamide and 0.5 lL of
ROX-labeled DNA size standards, both obtained from Applied
Biosystems. Electrokinetic injection of the DNA into the capillaries occurred at 2400 V for 23 sec. Amplicons were separated
using the POP-7 polymer and were analyzed using GeneMapper
v3.7 (Applied Biosystems). Using this system, MAOA alleles are
287 base pairs (bp), 317 bp, 335 bp, 347 bp, and 377 bp corresponding to alleles 2, 3, 3.5, 4, and 5, respectively (Fig. 1,
Panel a). As this gene is on the X chromosome, males will have
one allele generating a single peak at any of one of these sizes
while females may be homozygous for one allele to generate a
single peak or heterozygous for two different alleles generating
two distinct peaks. Using this methodology, the SLC6A4 short
allele yields amplicons 370 bp in length while the long allele
generates amplicons 412 bp in length (Fig. 1, Panel b). As this
gene is on an autosome, 17q11.2, an individual can be homozygous for either the short or long allele generating a single peak at
the corresponding size or heterozygous with both a short and long
allele with amplicons at 370 and 412 bp, respectively.
Results
The authors conducted MAOA and SLC6A4 genotyping on 15
defendants. See Table 6 for information regarding the defendants’
gender, age, charges, and results of MAOA and SLC6A4 genotyping. Most of the defendants had unremarkable results on genotyping. Several defendants (for example, ‘‘AA,’’ ‘‘CC,’’ ‘‘DD,’’
‘‘EE,’’ and ‘‘FF’’) had results that may be appropriate to present
regarding diminished capacity, mitigation, or waiver to criminal
court. By the time, this manuscript was submitted for publication,
the authors had limited experience in testifying regarding genotyping of defendants. Six case vignettes are summarized here.
Testimony Regarding ‘‘AA’’
AA was a 14-year-old Caucasian male who faced an unusual
number and intensity of psychosocial stressors. He became seriously depressed and suicidal, and one morning he woke up and
considered committing suicide that day. He obtained a handgun
from his father’s gun cabinet and loaded it. When it was time to

FIG. 1— Electropherograms obtained from the 3130 xl Genetic Analyzer
following amplification of genomic DNA by PCR for the MAOA (panel a)
and SLC6A4 (panel b) genes. DNA size standards labeled with the ROX
fluorophore are displayed as red and correspond to DNA fragments at 300,
340, and 350 in panel (a) and 340, 350, and 400 in panel (b). The intensity
of fluorescence measured by the instrument thus generating the peak height
for each allele is noted on the y-axis. MAOA alleles of 3 and 4 from a
female patient are displayed in green and denoted by arrows. SLC6A4 short
(S) and long (L) alleles from a patient heterozygous for this polymorphism
are displayed in black and denoted by arrows.
TABLE 6—Defendants who were genotyped.
Defendant

Gender ⁄ Age MAOA SLC6A4 Relevant charges

01
02
03

# ⁄ 20
# ⁄ 28
$ ⁄ 24

4
4
3⁄4

S⁄L
S⁄L
L⁄L

04

# ⁄ 44

4

L⁄L

05 (‘‘AA’’)
06
07 (‘‘BB’’)

# ⁄ 14
# ⁄ 40
# ⁄ 42

4
4
4

S⁄S
S⁄L
L⁄L

08 (‘‘CC’’)

# ⁄ 17

4

S⁄S

09
10 (‘‘DD’’)
11 (‘‘EE’’)

# ⁄ 27
# ⁄ 45
# ⁄ 29

4
4
3

L⁄L
S⁄L
S⁄S

12 (‘‘FF’’)
13
14
15

# ⁄ 45
# ⁄ 16
# ⁄ 26
# ⁄ 15

3.5
3
4
4

S⁄S
L⁄L
L⁄L
L⁄L

First-degree murder
First-degree murder
Attempted first-degree
murder
First-degree murder,
aggravated rape
First-degree murder
First-degree murder
First-degree murder
(2 counts),
Attempted first-degree
murder
First-degree murder
(2 counts)
First-degree murder
First-degree murder
First-degree murder
(2 counts)
First-degree murder (2 counts)
Reckless homicide
First-degree murder
First-degree murder, attempted
first-degree murder

‘‘Age’’ refers to the defendant’s age at the time of the alleged offense.
In MAOA genotyping, the ‘‘3’’and ‘‘3.5’’ alleles are associated with low
MAOA enzyme activity; the ‘‘4’’ allele is associated with high MAOA
enzyme activity. In SLC6A4 genotyping, the ‘‘S’’ or short allele is associated
with low serotonin transporter activity; the ‘‘L’’ or long allele is associated
with high serotonin transporter activity.
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go to school, AA approached the school bus and fatally shot the
bus driver.
On genetic testing, AA had the high activity MAOA allele
(4 repeats) and was homozygous, S ⁄ S, for the SLC6A4 gene. AA,
a juvenile, was transferred to criminal court. At the trial, one of us
(WB) testified for the defense and explained the significance of the
SLC6A4 genotyping, i.e., that AA had a genetic vulnerability to
become depressed under severe stress and that he was, in fact,
depressed. The prosecution did not object to the presentation of this
evidence. However, the testimony did not appear to have any effect
on the outcome of the trial; the jury found the defendant guilty of
first-degree murder.
Testimony Regarding ‘‘BB’’
BB was a 42-year-old Caucasian man who was accused of murdering his wife and daughter and attempting to murder his son. On
genetic testing, BB had the high activity MAOA allele (4 repeats)
and was homozygous, L ⁄ L, for the SLC6A4 gene. At BBs trial,
one of us (SAM) testified for the defense during the guilt phase of
the trial. Although the genotyping turned out not to be relevant to
the issues at the trial, the expert testified that genetic testing was
conducted as part of a comprehensive forensic evaluation. The
expert testified that no genetic factors were identified that might
predispose BB to violence. This was significant in that neither the
prosecution nor the court objected to the presentation of this
evidence.
Testimony Regarding ‘‘CC’’
CC was a 17-year-old Hispanic male day-laborer, who was
involved in the death of a pregnant woman. Reportedly, CC was a
passenger in a truck driven by a friend, who thought he struck and
injured the woman. When they returned to investigate, one or both
of the men shot and killed the woman and the unborn child. It was
not clear who shot the woman.
On genetic testing, CC had the high activity MAOA allele (4
repeats) and was homozygous, S ⁄ S, for the SLC6A4 gene. At
CCs trial, one of us (WB) planned to testify for the defense and
explain how CCs genetic makeup might have a bearing on the
issues of diminished capacity and mitigation. However, the prosecuting attorney objected to the nature of this testimony. Although
the judge ruled that the testimony was admissible, the prosecuting
attorney filed an interlocutory appeal to the Court of Criminal
Appeals in order to block the testimony of the defense expert.
The Tennessee Court of Criminal Appeals did not object to the
expert’s testimony regarding genotyping, but criticized the proposed testimony because the expert did not testify that the defendant completely lacked the mental capacity to commit the crimes
(43).
Testimony Regarding ‘‘DD’’
DD was a 45-year-old Caucasian male who killed an elderly
female storekeeper. He was found guilty of first-degree murder in
2002 and given the death penalty. As part of DDs direct appeal,
his attorney requested genetic testing for the MAOA and SLC6A4
genes. On genetic testing, DD had the high activity MAOA allele
(4 repeats) and was heterozygous, S ⁄ L, for the SLC6A4 gene.
This case is instructive because the court commented on the usefulness of genetic testing in the order authorizing the MAOA and
SLC6A4 genotyping. Regarding DD, the order said, ‘‘The Court
recognizes…the possibility that this information…might have
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influenced the jury’s decision in the penalty phase of the trial as
to whether to select death as the proper punishment for [DD].
…The Court finds, as a matter of law, that the expert services
sought are necessary to ensure that the constitutional rights of the
Defendant are properly protected.’’ The statement in the court
order suggests that not only is genetic testing acceptable to
present in a trial with a possible outcome of the death penalty,
but it might even be considered an expected component of the
individual’s defense.
Testimony Regarding ‘‘EE’’
EE was an approximately 25-year-old male who was charged
with two counts of first-degree murder, and his attorney requested
MAOA and SLC6A4 genotyping. On genetic testing, EE had the
low activity MAOA allele (3 repeats) and was homozygous, S ⁄ S,
for the SLC6A4 gene. EE had environmental factors that may
have interacted with the low activity MAOA allele (a history of
severe physical discipline) and the short alleles of the SLC6A4
gene (significant multiple stressors at the time of the alleged
offenses). This was our only case in which the defendant had
both of the G · E vulnerabilities discussed in this paper. EE's
defense team may want to introduce the results of the genetic
testing at his trial.
Testimony Regarding ‘‘FF’’
FF was a 43-year-old Caucasian male who found his estranged
wife and her boyfriend in bed together and shot and killed both
of them. FF was charged with two counts of first-degree murder.
One of us (WB) conducted a comprehensive pretrial forensic psychiatric evaluation on behalf of the defense, which included genotyping. On genetic testing, FF had the high activity MAOA allele
(4 repeats) and was homozygous, S ⁄ S, for the SLC6A4 gene. FF
had environmental factors that may have interacted with the short
allele of the SLC6A4 gene (multiple significant psychosocial
stressors).
At the trial, the forensic expert proposed to testify regarding the
issues of diminished capacity and mitigation. After a brief Daubert
hearing, however, the court ruled that behavioral genomics was not
yet scientific enough to present as testimony before a jury. The
expert was allowed to testify about other aspects of the evaluation,
but not regarding the genotyping.
Discussion and Conclusion
The authors of this paper are neither advocating nor criticizing
the presentation of evidence regarding a defendant’s genotype at a
criminal trial. We are simply presenting the current state of
research regarding this topic and our limited experience regarding
testimony. The research regarding G · E interaction summarized in
this paper is in an early stage of development, as is our testifying
about this research in criminal trials.
It seems possible that both the defense and the prosecution
may be interested in introducing evidence regarding a defendant’s
life experiences and genetic makeup to a jury. In a case of aggravated assault, for instance, the prosecution may say that a defendant has violent tendencies (based on the person’s genotype
conveying low MAOA activity and a history of severe child maltreatment), and should be removed from society for as long as
possible. On the other hand, the defense may say during the sentencing phase of a first-degree murder case that a person’s genotype and history of severe abuse during childhood is mitigating.
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That is, the defense attorney might argue that the person will at
least receive a life sentence and poses no future danger to society,
but the person should not receive the death penalty because his
behavior was at least partly caused by his genetic makeup and
his adverse life experiences.
The underlying science for the testimony discussed in this
paper is derived from several disciplines: in child development
and psychology, the ability to identify abused and nonabused
children in a systematic manner and follow them prospectively
for more than 20 years; in psychology and psychiatry, the ability
to collect reliable information regarding a person’s life experiences, psychological symptoms, and mental disorders; and in
molecular genetics, the ability to map the human genome and
identify genes that encode specific enzymes. The identification
and study of G · E interactions is an area of active research in
the field of psychiatric molecular genetics. Early research in this
area has created a roadmap for scientists interested in ‘‘investigating interactions between measured genes and measured environments’’ (44).
The future of behavioral genetics and the role of this new science
in criminal trials seems wide-open. This article addressed the possible usefulness of genotyping for only two genes as a component of
a pretrial forensic psychiatric evaluation when diminished capacity,
mitigation, and waiver to criminal court are issues. One can easily
imagine how other important legal issues might be addressed
through behavioral genetics. For example, perhaps specific groups
of genes will be identified that make a person vulnerable to serious
mental illnesses such as schizophrenia and bipolar disorder. Criminal defendants may seek testing for these gene variants to support a
claim of legal insanity. Also, perhaps specific groups of genes—
along with life experiences—will be identified that make a person
vulnerable to become a dangerous, intractable sex offender. Such
information may have a bearing on the decision to release such
individuals from institutions (either penal or psychiatric) into the
community. A rational approach to this ‘‘next frontier for the world
of criminal justice’’ (1) will require a foundation of solid science,
capable psychiatry, and good law.
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